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Transfusion-related Acute Lung Injury During Liver Transplant: Case Report
Nathanael A. Slater D.O., Nicholas C. Watson M.D.
Department of Anesthesia, University of Massachusetts Medical School, Worcester MA
Introduction TRALI: Definition and Current Concepts
Transfusion-related acute lung injury (TRALI) is defined as noncardiogenic 
pulmonary edema temporally related to the transfusion of blood products.1,2 We 
present a patient who, while undergoing orthotopic liver transplantation, 
developed acute pulmonary edema within minutes of administration of fresh 
frozen plasma (FFP).
Intraoperative  Course
A 71 year-old female presented for orthotopic liver transplantation.  She was 
TRALI: Figure 1. Intraoperative Diagnosis
At left: One of two containers of pulmonary edema 
suctioned from the patient’s ETT.  
At right: Sequential ABG’s obtained 
Brittingham reported the first link between symptoms of ALI, transfusion and 
leukoagglutinins in 1957.  The term TRALI was coined by Popovsky in 1983 
after describing a series of cases of ALI in association with leukoagglutinin in 
the blood component1.  Partially because of vigilance in preventing the spread 
of viral illness, TRALI has, according to the FDA, become the leading cause of 
morbidity and mortality associated with blood transfusion.  In 2005, the National 
Heart, Lung, and Blood Institute convened a panel to provide a clinically useful 
definition which is  “new ALI occurring during or within 6 hours after a 
ABG Post-Induction
Onset of 
TRALI Post-op
FiO2 40% 100% 60%
pH 7.32 7.11 7.36
brought to the operating room and underwent uneventful induction of general 
anesthesia, vascular access placement, and tracheal intubation.  The operative 
field was noted to have continual bleeding and blood products were 
administered to improve hemostasis.  Within minutes of administration of FFP, 
copious amounts of pale yellow, frothy fluid filled the endotracheal tube and the 
patient’s oxygen saturation dropped from 100% to 90%.  The patient was 
placed on 100% FiO2, intermittent suctioning removed 1L of fluid, and IV 
furosemide was given.  Hemodynamics and oxygenation stabilized, the 
operation was completed without further difficulty, including transfusion of 
additional blood products   
intraoperatively and immediately postop.  Induction 
was at 5:45 AM, transfusion of FFP occurred at 
6:45AM.  FiO2 at induction was 40% with 5 of 
PEEP on volume cycled ventilation. The second 
ABG is at 06:51 at which time copious amounts of 
fluid were being removed from the ETT via suction.  
FiO2 was 100%, PEEP 10.  Post-operatively, 
almost 12 hours later, ventlation, oxygenation, and 
respiratory mechanics had improved significantly.  
The patient was on 60% FiO with 5 of PEEP
,
transfusion, in patients with or without risk factors for ALI other than 
transfusion.”1 There are two theories as to how injury to the lung occurs in 
relation to transfusion.  One is the “Two Hit Hypothesis” which involves immune 
priming and the introduction of a TRALI producing agent3.  Priming sensitizes 
the vascular endothelium to a trigger which may the same agent at a higher 
dose or another agent entirely.  The trigger in TRALI appears to be lipids from 
stored blood3. The “Antibody Hypothesis” focuses on donor derived anti-
leukocyte antibodies that trigger increased vascular permeability in the lung.  
HLA class I and II from female, multiparous donors have been implicated in 
PaCO2 38 59 36
PaO2 138 129 108
HCO3 19.2 16.2 20
TRALI: Figure 2.  Imaging
.
SICU Course
The patient arrived in the SICU on 100% FiO2 and 10 of PEEP.  Vasopressin 
and norepinephrine were being administered due to persistent hypotension, 
likely secondary to large intravascular volume shifts during the procedure 
(approximately 7 liters of ascites were drained from her abdomen).  Over the 
next 36 hours, the goal of therapy shifted from volume resuscitation to diuresis 
and weaning from mechanical ventilation.  By the end of post-op day #2 the 
patient was on 40% FiO2 and spontaneously ventilating with CPAP.  Prolonged 
encephalopathy prevented successful extubation and the patient had a References
2 .
At left; Preop CXR 
demonstrating mild left 
lower lobe collapse, but 
otherwise clear lungs.
cases of TRALI1.  The components with the highest risk of producing TRALI are 
FFP and platelets1. Treatment is supportive, with sequelae resolving within 96 
hours of onset.  The incidence of TRALI in liver transplant patients is 1.3% and 
was found to be associated with plasma-containing products only (FFP, 
platelets)4.  Rate of infection was directly related to PRBC administration in a 
dose dependant manner4.  Given the complications related to transfusion, it is 
prudent to minimize transfusion of blood products as much as possible5. 
O2 sat% 99 98 100
tracheostomy placed post-op day #6.  She was successfully liberated from 
mechanical ventilation the next day.  The remainder of her hospital course was 
uneventful and she was discharged to rehab three weeks later.  As of this past 
January, on follow-up in transplant clinic, she is doing well, has a healthy 
appetite, and is able to participate in the day to day activities of her family life.  
She has had multiple type and screens drawn and her antibody screen remains 
persistently negative.  
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At right; CXR immediately 
post-op, showing diffuse 
bilateral infiltrates consistent 
with  pulmonary edema
TRALI: Differential diagnosis
The differential diagnosis of TRALI includes transfusion associated circulatory 
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Abbreviations
ABG: arterial blood gas
ALI: acute lung injury
ARDS: acute respiratory distress syndrome
CPAP: continuous positive airway pressure
CXR: chest x-ray
ETT: endotracheal tube
FDA: Food and Drug 
Administration
FFP: fresh frozen plasma
FiO2: fraction of inspired oxygen
PEEP: positive end expiratory 
pressure
TEE: transesophageal 
echocardiogram
TACO: transfusion-
associated circulatory 
overload 
-
overload (TACO), left ventricular failure, exacerbation or progression of ALI from 
another cause, ARDS, sepsis, trauma, smoke inhalation, aspiration pneumonitis 
or pneumonia.  The patient had no prior ALI, had no active infections, and had 
not been subject to trauma.  Intraoperative TEE demonstrated normal function 
of the left and right ventricles.  TACO was ruled out on the basis of preoperative 
hypovolemia, removal of 7 L of ascites, a normal TEE, no changes on EKG, and 
a temporal relationship with the transfusion of 2 units of FFP.
